Voltar
Revisão
BIBTEX RIS

Pre‐emptive (Neo‐adjuvant) Intravenous Chemotherapy for Invasive Bladder Cancer

1988; Wiley; Volume: 61; Issue: 1 Linguagem: Inglês

10.1111/j.1464-410x.1988.tb09152.x

ISSN

1365-2176

Autores

Derek Raghavan,

Tópico(s)

Metastasis and carcinoma case studies

Resumo

British Journal of UrologyVolume 61, Issue 1 p. 1-8 Pre-emptive (Neo-adjuvant) Intravenous Chemotherapy for Invasive Bladder Cancer D. RAGHAVAN, Corresponding Author D. RAGHAVAN Urological Cancer Research Unit, Royal Prince Alfred Hospital, Sydney, Australia D. Raghavan, PhD, FRACP, Research Director, Urological Cancer Research Unit and Senior Staff Oncologist, Department of Clinical Oncology.Urological Cancer Research Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia.Search for more papers by this author D. RAGHAVAN, Corresponding Author D. RAGHAVAN Urological Cancer Research Unit, Royal Prince Alfred Hospital, Sydney, Australia D. Raghavan, PhD, FRACP, Research Director, Urological Cancer Research Unit and Senior Staff Oncologist, Department of Clinical Oncology.Urological Cancer Research Unit, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia.Search for more papers by this author First published: January 1988 https://doi.org/10.1111/j.1464-410X.1988.tb09152.xCitations: 41 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Bloom, H. J. G., Hendry, W. F., Wallace, D. M. and Skeet, R. G. (1982). Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review (for the Clinical Trials Group, Institute of Urology). Br. J. Urol., 54, 136–151. 10.1111/j.1464-410X.1982.tb13537.x PubMedWeb of Science®Google Scholar Calais da Silva, F. and Denis, L. (1987). Pre-operative chemotherapy and cystectomy in invasive bladder cancer. In Treatment of Advanced Bladder Cancer: EORTC Monograph 5, ed. P. H. Smith and M. Pavone-Macaluso New York: Liss. (In press). Google Scholar Cooling, C. I. (1959). Review of 150 post-mortems of carcinoma of the urinary bladder. In Tumours of the Bladder, ed. D. M. Wallace Pp. 171–185. Edinburgh, London: Livingstone. Google Scholar Cummings, K. B., Shipley, W. U., Einstein, A. B. and Cutler, S. J. (1979). Current concepts in the management of patients with deeply invasive bladder cancer. Semin. Oncol., 6, 220–228. CASPubMedWeb of Science®Google Scholar Fagg, S. L., Dawson-Edwards, P., Hughes, M. A., Latief, T. N. Rolfe, E. B. and Fielding, J. W. L. (1984). Cis-diamminedi-chloro-platinum (DDP) as initial treatment of invasive bladder cancer. Br. J. Urol., 56, 296–300. 10.1111/j.1464-410X.1984.tb05390.x CASPubMedWeb of Science®Google Scholar Francini, M., Veronesi, A., Dal Bo, V., Carbone, A. and Monfardini, S. (1987). Neo-adjuvant chemotherapy in locally advanced bladder carcinoma. In Treatment of Advanced Bladder Cancer; EORTC Monograph 5, ed. P. H. Smith and M. Pavone-Macaluso New York: Liss. (In press). Google Scholar Goldie, J. and Coldman, A. J. (1979). A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep., 63, 1727–1733. CASPubMedWeb of Science®Google Scholar Hall, R. R., Newling, D. W., Ramsden, P. D., Richards, B., Robinson, M. R. G. and Smith, P. H. (1984). Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br. J. Urol., 56, 668–672. 10.1111/j.1464-410X.1984.tb06142.x CASPubMedWeb of Science®Google Scholar Hall, R. R., Roberts, T., Powell, P. H. and Marsh, M. M. (1987). Transurethral resection and chemotherapy or radiotherapy for invasive bladder cancer. In Treatment of Advanced Bladder Cancer: EORTC Monograph 5, ed. P. H. Smith and M. Pavone-Macaluso New York: Liss. (In press). Google Scholar Harker, W.G., Meyers, F. J., Freiha, F. S. et al. (1985). Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study. J. Clin. Oncol., 3, 1463–1470. 10.1200/JCO.1985.3.11.1463 CASPubMedWeb of Science®Google Scholar Herr, H. W. (1985). Pre-operative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology, 25, 127–134. 10.1016/0090-4295(85)90527-8 CASPubMedWeb of Science®Google Scholar Hillcoat, B. L. and Raghavan, D. (1986). A randomised comparison of cisplatinum (C) versus cisplatinum and methotrexate (C + M) in advanced bladder cancer. Proc. Am. Soc. Clin. Oncol., 5, 110 (Abstract). Google Scholar Jakse, G., Fritsch, E. and Frommhold, H. (1985). Combination of chemotherapy and irradiation of non-resectable bladder carcinoma. World J. Urol., 3, 121–125. 10.1007/BF00326720 Web of Science®Google Scholar Jakse, G. and Frommhold, H. (1987). Treatment of locally advanced bladder cancer by hyperfractionated radiotherapy and chemotherapy. In Treatment of Advanced Bladder Cancer: EORTC Monograph 5, ed. P. H. Smith and M. Pavone-Macaluso New York: Liss. (In press). Google Scholar Kanoh, S., Umeyama, T., Nemoto, S. et al. (1983). Long-term intra-arterial infusion chemotherapy with Adriamycin for advanced bladder cancer. Cancer Chemother. Pharmacol. (Suppl)., 11, 51–58. 10.1007/BF00256719 PubMedWeb of Science®Google Scholar Kaye, S. B., MacFarlane, J. R., McHattie, I. and Hart, A. J. L. (1985). Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study. Br. J. Urol., 57, 434–437. 10.1111/j.1464-410X.1985.tb06304.x CASPubMedWeb of Science®Google Scholar Kennedy, A. K., Feicber, B.A., Rockwell, S. and Sartorelli, A. C. (1980). The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem. Pharmacol., 29, 1–8. 10.1016/0006-2952(80)90235-X CASPubMedWeb of Science®Google Scholar Khandekar, J. D., Elson, P. J., DeWys, W. D., Slayton, R. E. and Harris D. T. (1985). Comparative activity and toxicity of cis-diammine dichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinoma of the urinary tract. J. Clin. Oncol., 3, 539–545. 10.1200/JCO.1985.3.4.539 CASPubMedWeb of Science®Google Scholar Logothetis, C. J., Samuels, M. L., Selig, D. E., Wallace, S. and Johnson, D. R. (1985). Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors. Cancer Treat. Rep., 69, 33–38. CASPubMedWeb of Science®Google Scholar Luk, K. H., Ross, G. Y., Phillips, T. L. and Goldstein, L. S. (1979) The interaction of radiation and cis-diamminedichlo-roplatinum (II) in intestinal crypt cells. Int. J. Rad. Oncol. Biol. Biophys., 5, 1417–1420. 10.1016/0360-3016(79)90681-3 CASPubMedWeb of Science®Google Scholar Maatman, T. J., Montie, J. E., Bukowski, R. M., Risius, B. and Geininger, M. (1986). Intra-arterial chemotherapy as an adjuvant to surgery in transitional cell carcinoma of the bladder. J. Urol., 135, 256–260. 10.1016/S0022-5347(17)45602-3 CASPubMedWeb of Science®Google Scholar Oliver, R. T. D. (1981). Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder. Cancer Treat. Rep (Suppl. I), 65, 179–181. PubMedWeb of Science®Google Scholar Pearson, B. S. and Raghavan, D. (1985). First-line intravenous cisplatin for deeply invasive bladder cancer: update on 70 cases. Br. J. Urol., 57, 690–693. 10.1111/j.1464-410X.1985.tb07033.x CASPubMedWeb of Science®Google Scholar Raghavan, D. (1985). First-line intravenous cisplatinum for invasive clinically non-metastatic bladder cancer. In Genitourinary Cancer, ed. M. B. Garnick Pp. 193–207. New York, Edinburgh, London: Churchill Livingstone. Google Scholar Raghavan, D. (1987). First-line intravenous chemotherapy for invasive bladder cancer. In The Management of Bladder Cancer, ed. D. Raghavan Pp. 285–298. London: Arnold. Google Scholar Raghavan, D., Pearson, B., Coorey, G. et al. (1984). Intravenous cis-platinum for invasive and clinically non-metastatic bladder cancer: safety and feasibility of a new approach. Med. J. Aust., 140, 276–278. 10.5694/j.1326-5377.1984.tb104036.x CASPubMedWeb of Science®Google Scholar Raghavan, D., Pearson, B. and Duval, P. (1986). First-line intravenous cisplatin in the treatment of invasive non-metastatic bladder cancer. In Neo-adjuvant Chemotherapy, ed. C. Jacquillat, M. Weil and D. Khayat Pp. 693–700. London, Paris: INSERM/John Libbey Eurotext. Google Scholar Raghavan, D., Pearson, B., Duval, P. et al (1985). Initial intravenous cis-platinum therapy: improved management for high risk bladder cancer?. J. Urol., 133, 399–402. 10.1016/S0022-5347(17)48995-6 CASPubMedWeb of Science®Google Scholar Rose, M. A. and Shipley, W. U. (1987). Radiotherapy in the management of bladder cancer: results and innovations. In The Management of Bladder Cancer, ed. D. Raghavan Pp. 154–188. London: Arnold. Web of Science®Google Scholar Rotman, M., Macchia, R., Silverstein, M. et al. (1987). Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion. Cancer, 59, 710–714. 10.1002/1097-0142(19870215)59:4 3.0.CO;2-U CASPubMedWeb of Science®Google Scholar Russell, P. J., Raghavan, D., Gregory, P. et al. (1986). Bladder cancer xenografts: a model of tumor cell heterogeneity. Cancer Res., 46, 2035–2040. CASPubMedWeb of Science®Google Scholar Scher, H. I., Yagoda, A., Sternberg, C. N. et al. (1986). Neoadjuvant MVAC for transitional cell carcinoma of the urothelium. Proc. Am. Soc. Clin. Oncol., 6, 419. (Abstract). Google Scholar Schulman, C. C., Wespes, E., Delcour, C. and Struyven, J. (1985). Intra-arterial chemotherapy of infiltrative bladder carcinoma. Eur. Urol., 11, 220–223. CASPubMedWeb of Science®Google Scholar Shipley, W. U., Coombs, L. J., Einstein, A. B., Jr., Soloway, M. S., Wajsman, Z., Prout G. R., Jr. and National Collaborative Bladder Cancer Group A (1984). Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J. Urol., 132, 899–903. 10.1016/S0022-5347(17)49938-1 CASPubMedWeb of Science®Google Scholar Simon, S. D. and Srougi, M. (1986). Neo-adjuvant M-VAC chemotherapy in invasive transitional cell carcinoma of the bladder: a pilot study. In Neo-adjuvant Chemotherapy, ed. C. Jacquillat, M. Weil and D. Khayat Pp. 701–704. London, Paris: INSERM/John Libbey Eurotext. Web of Science®Google Scholar Skinner, D. G. (1980). Current perspectives in the management of high grade invasive bladder cancer. Cancer, 45, 1866–1874. 10.1002/cncr.1980.45.s7.1866 CASPubMedWeb of Science®Google Scholar Soloway, M. S., Einstein, A., Corder, M. P. et al. (1983). A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. Cancer, 52, 767–772. 10.1002/1097-0142(19830901)52:5 3.0.CO;2-P CASPubMedWeb of Science®Google Scholar Soloway, M. S., Ikard, M. and Ford, K. (1981). Cis-diammine-dichloroplatinum (II) in locally advanced and metastic urothelial cancer. Cancer, 47, 476–480. 10.1002/1097-0142(19810201)47:3 3.0.CO;2-8 CASPubMedWeb of Science®Google Scholar Soloway, M. S., Ikard, M., Scheinberg, M. and Evans, J. (1982). Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report. J. Urol., 128, 1031–1033. 10.1016/S0022-5347(17)53330-3 CASPubMedWeb of Science®Google Scholar Steel, G. G. (1977). Growth Kinetics of Tumours. Pp. 5–55 and 217–307. Oxford: Oxford University Press. Google Scholar Steinberg, C. N., Yagoda, A., Scher, H. I. et al. (1985). Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol., 133, 403–407. PubMedWeb of Science®Google Scholar Sternberg, J. J., Bracken, R. B., Handel, P. B. and Johnson, D. E. (1977). Combination chemotherapy (CISCA) for advanced urinary tract carcinoma: a preliminary report. J.A.M.A., 238, 2282–2287. 10.1001/jama.238.21.2282 CASPubMedWeb of Science®Google Scholar Whitmore, W. F., Jr. (1980). Integrated irradiation and cystectomy for bladder cancer. Br. J. Urol., 52, 1–12. 10.1111/j.1464-410X.1980.tb02910.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume61, Issue1January 1988Pages 1-8 ReferencesRelatedInformation

Referência(s)